Saphenous Vein Allografts for Coronary Bypass

CryoLife

Status: Completed

Conditions: Coronary Artery Disease; Occlusion of Artery

Study type: Observational

Funder types: Industry

Identifiers

NCT01386021

AVG1101.001-M

Details and patient eligibility

About

The primary objective of this observational study is to evaluate the function (patency) of cryopreserved saphenous vein allografts used as coronary artery bypass grafts (CABG) for patients with occlusive coronary artery disease.

Full description

This Study is designed as a combination retrospective/prospective single center study in which all patients will be eligible for enrollment based on having a previous implant of CryoVein Saphenous Vein for CABG during the 2008-2010 time frame. A comprehensive chart review of former and previously implanted allograft patients will be performed for the retrospective portion of this Study. An effort will be made to include all patients from this site. Eligible patients will be consented into the Study for a single, prospective, observational imaging evaluation of their bypass conduits.

Enrollment: 1 patient

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any patient implanted with a CryoVein saphenous vein allograft for CABG during 2008 - 2010 time frame.
• Patients > 18 years of age at implant.

Exclusion criteria

• Patients < 18 years of age.

Trial design

1 participants in 1 patient group

Prior recipients of allografts for CABG